Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia

Authors :: Lloyd Einsiedel
Damian Purcell
Shane Schinke
Katelin Haynes
Graham P. Taylor
Fabiola Martin
Source :: Journal of Virus Eradication, Vol 4, Iss 1, Pp 48-50 (2018)
Publication Year :: 2018
Publisher :: Elsevier, 2018.
Abstract: We are pleased to report on the inaugural HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference joint with 2017 Australasian Sexual Health Conference in Canberra, Australia. Our understanding of HTLV-1 epidemiology, pathogenesis, laboratory diagnostics and treatment options for HTLV-1 diseases has advanced tremendously over the last 40 years. However, the awareness of healthcare providers and the general population about HTLV-1, and the effective promotion and implementation of HTLV-1 transmission-prevention strategies, lag behind current knowledge. Here we present a summary of the symposium, plenary and poster presentations on HTLV-1.

Subjects :: HTLV-1, HTLV-1-associated myelopathy/tropical spastic paraparesis, HAM/TSP, ATL, adult T cell leukaemia/lymphoma, human T leukaemic virus type 1, bronchiectasis, bronchiolitis, mortality, Australia, sexual transmission, treatment, service provision, patient feedback, serology
Microbiology
QR1-502
Public aspects of medicine
RA1-1270

Full Text Access

Tools